Search results for "Neoplastic"

showing 10 items of 2901 documents

Using A Heating Cable Within The Abdomen To Make Hyperthermic Intraperitoneal Chemotherapy Easier: Feasibility And Safety Study In The Swine

2009

International audience; BACKGROUND: Hyperthermic intraperitoneal chemotherapy (HIPEC) is a complex, expensive and time-consuming procedure. Despite its good results in the treatment of peritoneal carcinomatosis, these factors have precluded the wider use of this procedure around the world. We hypothesized that HIPEC could be performed by heating the liquid within the abdomen and thus avoiding the need for an external heating circuit and a pump. The aim of this study was to assess the feasibility and safety of an internal heating device for hyperthermic intraperitoneal chemotherapy in an experimental model. METHODS: Four large-white pigs underwent one-hour open intraperitoneal hyperthermia w…

Hyperthermiamedicine.medical_specialty[SDV.MHEP.CHI] Life Sciences [q-bio]/Human health and pathology/SurgerySwinemedicine.medical_treatmentAntineoplastic Agents[SDV.MHEP.CHI]Life Sciences [q-bio]/Human health and pathology/Surgery030230 surgery03 medical and health sciences0302 clinical medicineMedicineAnimals[ SDV.MHEP.CHI ] Life Sciences [q-bio]/Human health and pathology/SurgeryPeritoneal NeoplasmsChemotherapyThermal injurybusiness.industryExperimental modelCarcinomaPig modelGeneral MedicineEquipment DesignHyperthermia InducedNeoplasms Experimentalmedicine.disease3. Good healthSurgeryPeritoneal carcinomatosismedicine.anatomical_structureTreatment OutcomeOncology030220 oncology & carcinogenesisAbdomenFeasibility StudiesMedicineSurgeryHyperthermic intraperitoneal chemotherapyFemalebusinessInjections Intraperitoneal
researchProduct

Selection of suitable housekeeping genes for expression analysis in glioblastoma using quantitative RT-PCR

2009

Abstract Background Considering the broad variation in the expression of housekeeping genes among tissues and experimental situations, studies using quantitative RT-PCR require strict definition of adequate endogenous controls. For glioblastoma, the most common type of tumor in the central nervous system, there was no previous report regarding this issue. Results Here we show that amongst seven frequently used housekeeping genes TBP and HPRT1 are adequate references for glioblastoma gene expression analysis. Evaluation of the expression levels of 12 target genes utilizing different endogenous controls revealed that the normalization method applied might introduce errors in the estimation of…

Hypoxanthine PhosphoribosyltransferaseCell typeLung Neoplasmslcsh:QH426-470Journal ClubCellGene ExpressionComputational biologyBiologyBioinformaticsModels BiologicalVariable ExpressionReference genesExpression analysisGene expressionmedicineHumansStudent’s Sectionlcsh:QH573-671Molecular BiologyGeneSelection (genetic algorithm)GeneticsRegulation of gene expressionGenes Essentiallcsh:CytologyBrain NeoplasmsReverse Transcriptase Polymerase Chain ReactionMethodology ArticleGeneral NeuroscienceReference StandardsTATA-Box Binding Proteinmedicine.diseaseHousekeeping geneDNA-Binding ProteinsGene Expression Regulation Neoplasticlcsh:GeneticsNEOPLASIAS DO SISTEMA NERVOSOReal-time polymerase chain reactionmedicine.anatomical_structureGlioblastomaGlioblastomaAnnals of Neurosciences
researchProduct

Gated mesoporous silica nanoparticles for the controlled delivery of drugs in cancer cells

2015

In recent years, mesoporous silica nanoparticles (MSNs) have been used as effective supports for the development of controlled-release nanodevices that are able to act as multifunctional delivery platforms for the encapsulation of therapeutic agents, enhancing their bioavailability and overcoming common issues such as poor water solubility and poor stability of some drugs. In particular, redox-responsive delivery systems have attracted the attention of scientists because of the intracellular reductive environment related to a high concentration of glutathione (GSH). In this context, we describe herein the development of a GSH-responsive delivery system based on poly(ethylene glycol)- (PEG-)…

INGENIERIA DE LA CONSTRUCCIONCell SurvivalIntracellular SpaceNanoparticleNanotechnologyAntineoplastic AgentsCONTROLLED-RELEASETRIGGERED RELEASEPolyethylene Glycolschemistry.chemical_compoundINORGANIC NANOPARTICLESQUIMICA ORGANICASYSTEMSPEG ratioQUIMICA ANALITICAElectrochemistrymedicinePOLYMER HYBRID NANOPARTICLESGLUTATHIONEBIOQUIMICA Y BIOLOGIA MOLECULARHumansGeneral Materials ScienceDoxorubicinSpectroscopyDrug CarriersENHANCED PERMEABILITYQUIMICA INORGANICASurfaces and InterfacesGlutathioneIN-VITROMesoporous silicaCondensed Matter PhysicsSilicon DioxideControlled releaseGUEST MOLECULESBioavailabilityDrug LiberationchemistryDoxorubicinDelayed-Action PreparationsDrug DesignNanoparticlesPhenazinesSUPPORTSEthylene glycolOxidation-ReductionPorositymedicine.drugHeLa Cells
researchProduct

Cathepsin-B Induced Controlled Release from Peptide-Capped Mesoporous Silica Nanoparticles

2014

New capped silica mesoporous nanoparticles for intracellular controlled cargo release within cathepsin B expressing cells are described. Nanometric mesoporous MCM-41 supports loaded with safranin O (S1-P) or doxorubicin (S2-P) containing a molecular gate based on a cathepsin B target peptidic sequence were synthesized. Solids were designed to show "zero delivery" and to display cargo release in the presence of cathepsin B enzyme, which selectively hydrolyzed in vitro the capping peptide sequence. Controlled delivery in HeLa, MEFs WT, and MEFs lacking cathepsin B cell lines were also tested. Release of safranin O and doxorubicin in these cells took place when cathepsin B was active or presen…

INGENIERIA DE LA CONSTRUCCIONCell Survivalgated mesoporous materialsPeptideAntineoplastic AgentsCatalysisCathepsin BCell LineCathepsin BHeLaQUIMICA ORGANICAHumansCytotoxicityPeptide sequencechemistry.chemical_classificationDrug CarriersbiologyOrganic ChemistryQUIMICA INORGANICAGeneral ChemistryMesoporous silicabiology.organism_classificationSilicon DioxideControlled releasechemistryBiochemistryDoxorubicinBiophysicspeptidesnanoparticlescontrolled releasePorosityIntracellularHeLa Cells
researchProduct

Amidase-responsive controlled release of antitumoral drug into intracellular media using gluconamide-capped mesoporous silica nanoparticles

2012

MCM-41 silica nanoparticles were used as inorganic scaffolding to prepare a nanoscopic-capped hybrid material S1, which was able to release an entrapped cargo in the presence of certain enzymes, whereas in the absence of enzymes, a zero release system was obtained. S1 was prepared by loading nanoparticles with Safranine O dye and was then capped with a gluconamide derivative. In the absence of enzymes, the release of the dye from the aqueous suspensions of S1 was inhibited as a result of the steric hindrance imposed by the bulky gluconamide derivative, the polymerized gluconamide layer and the formation of a dense hydrogen-bonded network around the pore outlets. Upon the addition of amidase…

INGENIERIA DE LA CONSTRUCCIONMaterials scienceCell SurvivalNanoparticleAntineoplastic AgentsElectron Microscopy Service of the UPVGluconatesAmidaseAmidohydrolasesHydrolysisQUIMICA ORGANICAEnzymatic hydrolysisPeptide bondOrganic chemistryHumansGeneral Materials ScienceDrug effectsMicroscopy ConfocalQUIMICA INORGANICAHydrogen BondingMesoporous silicaSilicon DioxideControlled releaseCombinatorial chemistryMCF-7 CellsNanoparticlesCamptothecinHybrid materialLysosomesPorosityHeLa Cells
researchProduct

Expression profiling of autoimmune regulator AIRE mRNA in a comprehensive set of human normal and neoplastic tissues.

2006

Defects in the autoimmune regulator (AIRE) gene cause the monogenic autoimmune disease autoimmune polyendocrinopathy syndrome type 1 (APS-1), which is characterized by a loss of self-tolerance to multiple organs. In concordance with its role in immune tolerance, AIRE is strongly expressed in medullary thymic epithelial cells (mTECs). Data on mechanisms controlling AIRE activation and the expression of this gene in other tissues are fragmentary and controversial. We report here AIRE mRNA expression profiling of a large set of normal human tissues and cells, tumor specimen and methylation deficient cell lines. On this broad data basis we found that AIRE mRNA expression is confined to mTECs in…

Immune Tolerance/geneticsThymus Gland/immunologyTranscription GeneticImmunologyTranscription Genetic/immunologyThymus GlandBiologyLymph Nodes/immunologymedicine.disease_causeAutoimmunityImmune toleranceCell Line TumorNeoplasmsmedicineTranscriptional regulationImmune ToleranceImmunology and AllergyHumansRNA MessengerPolyendocrinopathies AutoimmuneGeneTranscription Factors/biosynthesisAutoimmune diseaseReverse Transcriptase Polymerase Chain ReactionGene Expression ProfilingRNA Messenger/biosynthesisDNA Methylationmedicine.diseaseAutoimmune regulatorNeoplasms/geneticsPolyendocrinopathies Autoimmune/geneticsGene expression profilingGene Expression Regulation NeoplasticDNA methylationImmunologyCancer researchLymph NodesGene Expression Profiling/methodsTranscription FactorsImmunology letters
researchProduct

MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer.

2013

It is now largely admitted that a pro-inflammatory environment may curtail anti-tumor immunity and favor cancer initiation and progression. The discovery that small non-coding regulatory RNAs, namely microRNAs (miRNAs), regulate all aspects of cell proliferation, differentiation, and function has shed a new light on regulatory mechanisms linking inflammation and cancer. Thus, miRNAs such as miR-21, miR-125b, miR-155, miR-196, and miR-210 that are critical for the immune response or hypoxia are often overexpressed in cancers and leukemias. Given the high number of their target transcripts, their deregulation may have a number of deleterious consequences, depending on the cellular context. In…

ImmunologyBiologyBioinformaticsmedicine.disease_causemiR-155Transforming Growth Factor betaNeoplasmsmicroRNAmedicineImmunology and AllergyAnimalsHumansTranscription factorCell ProliferationRegulation of gene expressionInflammationImmunityBiological TherapyGene Expression Regulation NeoplasticMicroRNAsCell Transformation NeoplasticTumor EscapeCancer researchTumor EscapeSignal transductionCarcinogenesisTransforming growth factorSignal TransductionTranscription FactorsImmunological reviews
researchProduct

Serological identification of HSP105 as a novel non-Hodgkin lymphoma therapeutic target.

2011

Abstract We reported that the clinical efficacy of dendritic cell–based vaccination is strongly associated with immunologic responses in relapsed B-cell non-Hodgkin lymphoma (B-NHL) patients. We have now investigated whether postvaccination antibodies from responders recognize novel shared NHL-restricted antigens. Immunohistochemistry and flow cytometry showed that they cross-react with allogeneic B-NHLs at significantly higher levels than their matched prevaccination samples or nonresponders' antibodies. Western blot analysis of DOHH-2 lymphoma proteome revealed a sharp band migrating at approximately 100 to 110 kDa only with postvaccine repertoires from responders. Mass spectrometry ident…

ImmunologyMice SCIDBiochemistryAntibodiesFlow cytometryAntigen-Antibody ReactionsCohort StudiesHSP105MiceAntigenhemic and lymphatic diseasesCell Line TumormedicineAnimalsHumansSerologic TestsHSP110 Heat-Shock Proteinsmedicine.diagnostic_testbiologybusiness.industryLymphoma Non-HodgkinHSP105; non-Hodgkin lymphoma.Cell BiologyHematologyCell cyclemedicine.diseaseImmunohistochemistryLymphomaGranzyme BGene Expression Regulation Neoplasticnon-Hodgkin lymphoma.Spectrometry Mass Matrix-Assisted Laser Desorption-IonizationImmunologybiology.proteinImmunohistochemistryAntibodybusinessDiffuse large B-cell lymphoma
researchProduct

Synthesis and antiproliferative activity of 3-amino-N-phenyl-1H-indazole-1-carboxamides

2007

Abstract A series of new 3-amino-N-phenyl-1H-indazole-1-carboxamides 10 have been prepared from commercially available phenyl isocyanate precursors 8 and 3-aminoindazole 9. Some of the synthesized compounds were evaluated for their in vitro antineoplastic activity against 60 human cell lines derived from seven clinically isolated cancer types (lung, colon, melanoma, renal, ovarian, brain, and leukemia) according to the NCI standard protocol. The test results indicated that 3-amino-1H-indazole-1-carboxamides 10 were endowed with an interesting antiproliferative activity. The most active compounds of this series, 10d,e, were able to inhibit cell growth of many neoplastic cell lines at concent…

IndazolesAntineoplastic AgentsCrystallography X-RayRetinoblastoma Proteinchemistry.chemical_compoundStructure-Activity RelationshipCell Line TumorNeoplasmsDrug DiscoverymedicineHumansCell ProliferationG0-G1 arrestPharmacologyIndazoleMolecular StructureChemistryCell growthMelanomaOrganic ChemistryCell CycleCancer1H-Indazole-1-carboxamides; Crystallographic study; G0-G1 arrest; pRb1H-Indazole-1-carboxamideGeneral MedicineCell cyclemedicine.diseaseAmidesSettore CHIM/08 - Chimica FarmaceuticaIn vitroCrystallographyc studyLeukemiapRbBiochemistryNeoplastic cell
researchProduct

Synthesis and Antiproliferative Activity of Novel 3-(Indazol-3-yl)-quinazolin-4(3H)-one and 3-(Indazol-3-yl)-benzotriazin-4(3H)-one Derivatives

1999

Several new 3-(indazol-3-yl)-quinazolin-4(3H)-one and 3-(indazol-3-yl)-benzotriazin-4(3H)-one derivatives 5 and 6 were synthesized and tested for their in vitro antiproliferative activity against Raji, K562, and K562-R cell lines. The pharmacological screening showed that some 2, 6, or 7-substituted quinazolinones 5 posses a significant antiproliferative activity, with a percentage growth inhibition ranging from 44.8% to 100% at 50 microM, which was higher than that showed by the unsubstituted derivative 5a previously synthesized. For the most active compounds 5d, 5f, and 5g the IC50 were recorded.

IndazolesMagnetic Resonance SpectroscopyChemical PhenomenaBicyclic moleculeChemistry PhysicalTriazinesCell growthStereochemistryPharmaceutical ScienceAntineoplastic AgentsChemical synthesisIn vitrochemistry.chemical_compoundchemistryCell cultureDrug DiscoveryQuinazolinesTumor Cells CulturedLactamHumansGrowth inhibitionIC50Archiv der Pharmazie
researchProduct